Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record.

Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto‐ATPase

Open access
Crack, B.E., Pollard, C.E., Beukers, M.W., Roberts, S.M., Hunt, S.F., Ingall, A.H., McKechnie, K.C.W., IJzerman, A.P., Leff, P.·1995·British Journal of Pharmacology

Abstract

FPL 67156 (6‐N,N‐diethyl‐β,γ‐dibromomethylene‐d‐ATP), is a newly synthesized analogue of ATP. In a rabbit isolated tracheal epithelium preparation, measuring P 2U‐purinoceptor‐dependent chloride secretion, FPL 67156 was discovered to potentiate the responses to UTP but not those to ATP‐γ‐S. UTP agonist‐concentration effect (E/[A]) curves were shifted to the left by 5‐fold in the presence of 100 μ m FPL 67156. The differential effect of FPL 67156 on UTP and ATP‐γ‐S was hypothesized to be due to the greater susceptibility of UTP to enzymatic dephosphorylation and the ability of FPL 67156 to inhibit this process. FPL 67156 was tested as an ecto‐ATPase inhibitor in a human blood cell assay, measuring [γ 32 P]‐ATP dephosphorylation. The compound inhibited [γ 32 P]‐ATP degradation with a pIC 50 of 4.6. FPL 67156 was then tested for its effects on ATP and α,β‐methylene‐ATP responses at P 2X‐purinoceptors in the rabbit isolated ear artery. In the concentration range 30 μ m‐1 m m, the compound potentiated the contractile effects of ATP but not those of α,β‐methylene‐ATP. At 1 m m, FPL 67156 produced a 34‐fold leftward shift of ATP E/[A] curves. The effects of FPL 67156 on ATP E/[A] curves in the rabbit ear artery were analysed using a theoretical model (Furchgott, 1972) describing the action of an enzyme inhibitor on the effects of a metabolically unstable agonist. This analysis provided an estimate of the p K1 for FPL 67156 as an ecto‐ATPase inhibitor of 5.2. Using appropriate assays, FPL 67156 was shown to have weak antagonist effects at P 2X‐ and P 2T‐purinoceptors (p A2 ≅ 3.3 and 3.5 respectively), and weak agonist effects at P 2U‐purinoceptors (p[A50] ≅ 3.5). The degree of potentiation of ATP and UTP effects elicited by FPL 67156 confirms previous results concerning the influence that ecto‐ATPase has on the position of E/[A] curves for metabolically unstable agonists. The magnitude of this influence is predicted to have a major effect on the agonist potency orders currently used to designate purinoceptors. This study indicates FPL 67156 to be a potentially valuable probe in studies on the action of nucleotides and in the classification of purinoceptors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.1995.tb13251.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 181

Metadata

Authors
Crack, B. E., Pollard, C. E., Beukers, M. W., Roberts, S. M., Hunt, S. F., Ingall, A. H., McKechnie, K. C. W., IJzerman, A. P., & Leff, P.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1995-01
Volume
114
Issue
2
Pages
475-481
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1982985630
Cited by
181
References
0
FWCI
9.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto‐ATPase. https://app.cochat.ai/papers/10.1111/j.1476-5381.1995.tb13251.x
The paper
Crack, B. E., Pollard, C. E., Beukers, M. W., Roberts, S. M., Hunt, S. F., Ingall, A. H., McKechnie, K. C. W., IJzerman, A. P., & Leff, P. (1995). Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto‐ATPase. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1995.tb13251.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.